0001437749-21-002956.txt : 20210216 0001437749-21-002956.hdr.sgml : 20210216 20210216134925 ACCESSION NUMBER: 0001437749-21-002956 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210216 DATE AS OF CHANGE: 20210216 EFFECTIVENESS DATE: 20210216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gila Therapeutics, Inc. CENTRAL INDEX KEY: 0001673503 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-389531 FILM NUMBER: 21635844 BUSINESS ADDRESS: STREET 1: 1712 HUMBOLT AVENUE SOUTH CITY: MINNEAPOLIS STATE: MN ZIP: 55403 BUSINESS PHONE: 612-805-9054 MAIL ADDRESS: STREET 1: 1712 HUMBOLT AVENUE SOUTH CITY: MINNEAPOLIS STATE: MN ZIP: 55403 D 1 primary_doc.xml X0708 D LIVE 0001673503 Gila Therapeutics, Inc. 5420 Highwood Dr W Minneapolis MN MINNESOTA 55436 612-805-9054 DELAWARE None None Corporation true Scott Schorer 5420 Highwood Dr W Minneapolis MN MINNESOTA 55436 Executive Officer Director Jon Freeman 5420 Highwood Dr W Minneapolis MN MINNESOTA 55436 Executive Officer Tom Vasicek 5420 Highwood Dr W Minneapolis MN MINNESOTA 55436 Executive Officer Christopher de Souza 5420 Highwood Dr W Minneapolis MN MINNESOTA 55436 Director Richard Horan 5420 Highwood Dr W Minneapolis MN MINNESOTA 55436 Director Biotechnology Decline to Disclose 06b false 2021-01-29 false true true false 0 500000 401934 98066 false 17 0 0 0 false Gila Therapeutics, Inc. /s/ Scott Schorer Scott Schorer Chief Executive Officer 2021-02-16